Compare NPCE & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | MAGN |
|---|---|---|
| Founded | 1997 | 1864 |
| Country | United States | United States |
| Employees | N/A | 8500 |
| Industry | Medical Specialities | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 316.5M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | MAGN |
|---|---|---|
| Price | $15.48 | $10.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $18.33 | $12.00 |
| AVG Volume (30 Days) | 165.9K | ★ 492.7K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | $5.37 |
| Revenue Next Year | $24.46 | $3.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $7.82 |
| 52 Week High | $18.97 | $15.52 |
| Indicator | NPCE | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 50.64 |
| Support Level | $15.25 | $8.82 |
| Resistance Level | $15.71 | $12.09 |
| Average True Range (ATR) | 0.67 | 0.43 |
| MACD | 0.22 | 0.28 |
| Stochastic Oscillator | 91.26 | 82.60 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.